MedTrace Logo

Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma

NCT03770468 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 599

Last updated 2024-03-08

No results posted yet for this study

Summary

This pro - and retrospective multicenter clinical epidemiological study studies the molecular genetic, host-derived and clinical determinants of glioblastoma patients with an overall survival of more than 5 years. The different research focusses are:

* Identification of clinical parameters and patient characteristics / host-related factors in long-term survivors (Focus 1)
* Identification of molecular tumor characteristics in long-term survivors (Focus 2)
* Assessment of therapy-related parameters, including neuro-toxicity (Focus 3)
* Immunological studies (Focus 4)

Conditions

Interventions

PROCEDURE

Blood drawl

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Michael Weller · EORTC Study Coordinator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-05
Primary Completion
2023-08-18
Completion
2023-08-18

Countries

  • United States
  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Italy
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770468 on ClinicalTrials.gov